2016 Annual Meeting

International Society of Bone and Soft Tissue Pathology

Room CC 608-609, March 13 2016, 1:30pm to 5:00pm

Description

International Society of Bone and Soft Tissue Pathology

The Evolving Concepts of Mesenchymal Tumor

Session Credits: 3 CME and 3 SAMs

Sunday, March 13, 2016
1:30 PM 5:00 PM

Moderators: Jean-Michel Coindre, MD, Institut Bergoni, Bordeaux, France
Cristina R. Antonescu, MD, Memorial Sloan-Kettering Center, New York, NY

Course description:
The symposium theme and content is selected by the President with input from the Society’s executive officers of the International Society of Bone and Soft Tissue Pathology. The agenda has been designed to meet the educational needs of general surgical pathologists as well as bone and soft tissue tumor subspecialists who are involved in the management of patients with mesenchymal neoplasms. During the last 20 years, the classification of mesenchymal neoplasms has witnessed striking transformation. In this companion meeting, the evolution of concepts regarding important mesenchymal tumor families is emphasized concurrent with new developments and application, particularly in molecular biology.

Upon completion of this activity, participants should be better able to:

  1. Understand important concepts regarding mesenchymal tumor families
  2. Recognize recent developments in genomic mechanisms in soft tissue and bone tumors
  3. Describe the role of biomarkers in the diagnostic classification and management of soft tissue and bone tumors.
  4. Associate morphologic variants with specific genetic changes

Agenda

1:30 PM Opening Remarks
Jean-Michel Coindre, MD, Institut Bergoni, Bordeaux, France
1:35 PM MDM2 Amplified Sarcomas
Raf Sciot, MD, KU Leuven, Leuven, Belgium
2:05 PM GIST: From Leiomyoblastoma to Wild Type GIST
Markku M. Miettinen, MD, National Cancer Institute, Bethesda, MD
2:35 PMEwing and Ewing-like Sarcomas
Cristina R. Antonescu, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
3:05 PMBreak
3:30 PM SWI/SNF Dependent Tumors
Franois Le Loarer, MD, Centre Lon Brard, Lyon, France
4:00 PMALK Fusion Positive Mesenchymal Tumors
Jason L. Hornick, MD, Brigham and Women’s Hospital, Boston, MA
4:30 PM Concluding Remarks
Cristina R. Antonescu, MD, Memorial Sloan-Kettering Center, New York, NY

Meetings

home-circle-inset-1
view more